Susunod

Auto-play

Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD

6 Mga view • 07/30/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play